Daraxonrasib (RMC-6236) CAS No.: 2765081-21-6 is an orally active, non-covalent RAS (ON) inhibitor. Daraxonrasib disrupts the interaction of wild-type or mutant RAS proteins with the RAS binding domain of BRAF, with EC50 values ranging from 28-220 nM for wild-type KRAS, NRAS, HRAS, and multiple oncogenic RAS variants. Daraxonrasib inhibits pERK. Daraxonrasib has anti-tumor activity against KRAS mutant tumors.
Related Products:
Zoldonrasib (RMC-9805; KRAS G12D inhibitor 18) CAS No.: 2922732-54-3 https://www.chemshuttle.com/catalogsearch/result/?q=2922732-54-3&cat=
RMC-7977 CAS No.: 2765082-12-8 https://www.chemshuttle.com/catalogsearch/result/?q=2765082-12-8&cat=
RMC-4998 CAS No.: 2642037-07-6 https://www.chemshuttle.com/catalogsearch/result/?q=2642037-07-6&cat=
Elironrasib (RMC-6291) CAS No.: 2641998-63-0 https://www.chemshuttle.com/catalogsearch/result/?q=2641998-63-0&cat=
RMC-5127 CAS No.: 3056146-38-1 https://www.chemshuttle.com/catalogsearch/result/?q=3056146-38-1&cat=
RM-018 CAS No.: 2641993-55-5 https://www.chemshuttle.com/catalogsearch/result/?q=2641993-55-5&cat=
RAS/RAS-RAF-IN-1 CAS No.: 2447039-81-6 https://www.chemshuttle.com/catalogsearch/result/?q=2447039-81-6&cat=